Follow
Marc Lobbes
Marc Lobbes
Assistant professor Radiology
Verified email at mumc.nl
Title
Cited by
Cited by
Year
Supplemental MRI screening for women with extremely dense breast tissue
MF Bakker, SV de Lange, RM Pijnappel, RM Mann, PHM Peeters, ...
New England Journal of Medicine 381 (22), 2091-2102, 2019
5332019
Breast implants and the risk of anaplastic large-cell lymphoma in the breast
M de Boer, FE van Leeuwen, M Hauptmann, LIH Overbeek, JP de Boer, ...
JAMA oncology 4 (3), 335-341, 2018
3132018
The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic …
MBI Lobbes, R Prevos, M Smidt, VCG Tjan-Heijnen, M Van Goethem, ...
Insights into imaging 4, 163-175, 2013
2342013
Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme
MBI Lobbes, U Lalji, J Houwers, EC Nijssen, PJ Nelemans, ...
European radiology 24, 1668-1676, 2014
2292014
Contrast-enhanced mammography: state of the art
MS Jochelson, MBI Lobbes
Radiology 299 (1), 36-48, 2021
2072021
MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial
S Saadatmand, HA Geuzinge, EJT Rutgers, RM Mann, ...
The Lancet Oncology 20 (8), 1136-1147, 2019
1612019
Contrast enhanced mammography: techniques, current results, and potential indications
MBI Lobbes, ML Smidt, J Houwers, VC Tjan-Heijnen, JE Wildberger
Clinical radiology 68 (9), 935-944, 2013
1602013
Evaluation of low-energy contrast-enhanced spectral mammography images by comparing them to full-field digital mammography using EUREF image quality criteria
UC Lalji, C Jeukens, I Houben, PJ Nelemans, RE van Engen, ...
European radiology 25, 2813-2820, 2015
1572015
Contrast enhanced spectral mammography: a review
BK Patel, MBI Lobbes, J Lewin
Seminars in Ultrasound, CT and MRI 39 (1), 70-79, 2018
1502018
Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study
UC Lalji, IPL Houben, R Prevos, S Gommers, M Van Goethem, ...
European radiology 26, 4371-4379, 2016
1402016
The quality of tumor size assessment by contrast-enhanced spectral mammography and the benefit of additional breast MRI
MBI Lobbes, UC Lalji, PJ Nelemans, I Houben, ML Smidt, E Heuts, ...
Journal of Cancer 6 (2), 144, 2015
1342015
Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging
U Bick, RM Trimboli, A Athanasiou, C Balleyguier, PAT Baltzer, ...
Insights into imaging 11, 1-18, 2020
1302020
MR imaging as an additional screening modality for the detection of breast cancer in women aged 50–75 years with extremely dense breasts: the DENSE trial study design
MJ Emaus, MF Bakker, PHM Peeters, CE Loo, RM Mann, MDF De Jong, ...
Radiology 277 (2), 527-537, 2015
1272015
Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre …
LM Van Roozendaal, MLG Vane, T Van Dalen, JA van der Hage, ...
BMC cancer 17, 1-8, 2017
1202017
The role of MRI in axillary lymph node imaging in breast cancer patients: a systematic review
VJL Kuijs, M Moossdorff, RJ Schipper, RGH Beets-Tan, EM Heuts, ...
Insights into imaging 6, 203-215, 2015
1202015
A novel less-invasive approach for axillary staging after neoadjuvant chemotherapy in patients with axillary node-positive breast cancer by combining radioactive iodine seed …
TJA van Nijnatten, JM Simons, ML Smidt, CC van der Pol, PJ van Diest, ...
Clinical breast cancer 17 (5), 399-402, 2017
1152017
Radiation exposure of contrast-enhanced spectral mammography compared with full-field digital mammography
CR Jeukens, UC Lalji, E Meijer, B Bakija, R Theunissen, JE Wildberger, ...
Investigative radiology 49 (10), 659-665, 2014
1152014
Contrast-enhanced spectral mammography is comparable to MRI in the assessment of residual breast cancer following neoadjuvant systemic therapy
BK Patel, T Hilal, M Covington, N Zhang, HE Kosiorek, M Lobbes, ...
Annals of surgical oncology 25, 1350-1356, 2018
1122018
Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients
B Goorts, TJA van Nijnatten, L de Munck, M Moossdorff, EM Heuts, ...
Breast cancer research and treatment 163, 83-91, 2017
1122017
Supplemental breast MRI for women with extremely dense breasts: results of the second screening round of the DENSE trial
SGA Veenhuizen, SV de Lange, MF Bakker, RM Pijnappel, RM Mann, ...
Radiology 299 (2), 278-286, 2021
1092021
The system can't perform the operation now. Try again later.
Articles 1–20